ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 144 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,408,000 | -5.4% | 450,013 | -0.5% | 0.00% | 0.0% |
| Q3 2016 | $2,546,000 | +2.8% | 452,264 | +0.3% | 0.00% | 0.0% |
| Q2 2016 | $2,476,000 | -17.3% | 451,008 | +11.7% | 0.00% | -25.0% |
| Q1 2016 | $2,995,000 | -6.3% | 403,628 | +4.9% | 0.00% | 0.0% |
| Q4 2015 | $3,197,000 | -7.3% | 384,700 | +0.5% | 0.00% | -20.0% |
| Q3 2015 | $3,449,000 | -26.0% | 382,780 | -1.4% | 0.01% | -16.7% |
| Q2 2015 | $4,658,000 | +63.4% | 388,191 | +46.6% | 0.01% | +50.0% |
| Q1 2015 | $2,851,000 | +140.4% | 264,738 | +13.2% | 0.00% | +100.0% |
| Q4 2014 | $1,186,000 | +88.6% | 233,911 | -1.8% | 0.00% | +100.0% |
| Q3 2014 | $629,000 | -34.1% | 238,224 | +0.5% | 0.00% | 0.0% |
| Q2 2014 | $955,000 | -6.6% | 237,016 | +6.2% | 0.00% | 0.0% |
| Q1 2014 | $1,022,000 | +7.7% | 223,221 | +2.1% | 0.00% | 0.0% |
| Q4 2013 | $949,000 | +26.0% | 218,717 | +14.5% | 0.00% | 0.0% |
| Q3 2013 | $753,000 | +96.1% | 190,990 | +4.9% | 0.00% | 0.0% |
| Q2 2013 | $384,000 | – | 182,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $51,946,000 | 2.80% |
| MILLER VALUE PARTNERS, LLC | 4,900,721 | $26,219,000 | 1.15% |
| MSD Partners, L.P. | 3,410,500 | $18,246,000 | 0.92% |
| Michael & Susan Dell Foundation | 66,749 | $357,000 | 0.26% |
| Glacier Peak Capital LLC | 68,043 | $364,000 | 0.21% |
| Vident Investment Advisory, LLC | 114,980 | $615,000 | 0.08% |
| SFMG, LLC | 62,433 | $334,000 | 0.07% |
| Virtus ETF Advisers LLC | 40,359 | $216,000 | 0.06% |
| Steward Partners Investment Advisory, LLC | 23,187 | $124,000 | 0.06% |
| O'Dell Group, LLC | 10,142 | $54,000 | 0.05% |